Shandong Weigao Group Medical Polymer Company Limited
SHWGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $6,644,048 | $6,451,383 | $6,635,688 | $6,331,753 |
| % Growth | 3% | -2.8% | 4.8% | – |
| Cost of Goods Sold | $3,340,540 | $3,292,254 | $3,259,245 | $3,264,462 |
| Gross Profit | $3,303,508 | $3,159,129 | $3,376,443 | $3,067,291 |
| % Margin | 49.7% | 49% | 50.9% | 48.4% |
| R&D Expenses | $315,532 | $470,182 | $301,613 | $436,826 |
| G&A Expenses | $619,961 | $753,830 | $539,773 | $712,205 |
| SG&A Expenses | $1,812,231 | $1,824,742 | $1,811,819 | $1,966,025 |
| Sales & Mktg Exp. | $1,179,675 | $1,070,628 | $1,264,556 | $1,261,130 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,127,763 | $2,294,924 | $2,113,432 | $2,336,536 |
| Operating Income | $1,175,745 | $864,205 | $1,263,011 | $918,933 |
| % Margin | 17.7% | 13.4% | 19% | 14.5% |
| Other Income/Exp. Net | $50,159 | $323,164 | $103,368 | -$18,085 |
| Pre-Tax Income | $1,225,904 | $1,187,369 | $1,366,379 | $900,848 |
| Tax Expense | $168,919 | $178,223 | $212,809 | $82,318 |
| Net Income | $1,008,317 | $959,119 | $1,107,549 | $804,139 |
| % Margin | 15.2% | 14.9% | 16.7% | 12.7% |
| EPS | 0.22 | 0.2 | 0.24 | 0.175 |
| % Growth | 10% | -16.7% | 37.5% | – |
| EPS Diluted | 0.22 | 0.2 | 0.24 | 0.178 |
| Weighted Avg Shares Out | 4,583,301 | 4,665,566 | 4,614,788 | 4,607,824 |
| Weighted Avg Shares Out Dil | 4,543,115 | 4,569,488 | 4,614,788 | 4,529,926 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $111,806 | $0 | $103,777 |
| Interest Expense | $116,773 | $0 | $128,776 | $0 |
| Depreciation & Amortization | $462,651 | $486,851 | $434,826 | $581,306 |
| EBITDA | $1,638,396 | $1,497,618 | $1,697,837 | $1,384,280 |
| % Margin | 24.7% | 23.2% | 25.6% | 21.9% |